These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 216823)

  • 21. Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma--a pilot study.
    Mason BA; Richter MP; Catalano RB; Creech RB
    Cancer Treat Rep; 1982 Aug; 66(8):1609-12. PubMed ID: 6286119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Small cell bronchial carcinoma. Possibilities and results of chemotherapy].
    Niederle N
    ZFA (Stuttgart); 1984 Jan; 60(3):104-8. PubMed ID: 6324504
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy for lung cancer.
    Golbey RB
    Postgrad Med; 1978 Feb; 63(2):137-41. PubMed ID: 75540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
    Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
    Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H; Brugarolas A; Mittelman A; Vincent R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract]   [Full Text] [Related]  

  • 27. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
    Dana M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
    [No Abstract]   [Full Text] [Related]  

  • 28. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
    Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
    Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of the effectiveness of N-nitrosomethylurea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea combined with cyclophosphane in inoperable lung cancer].
    Assekritova IV; Perevodchikova NI; Batinov IN; Bychkov MB; Vaarik KhM
    Vestn Akad Med Nauk SSSR; 1978; (9):87-90. PubMed ID: 214971
    [No Abstract]   [Full Text] [Related]  

  • 30. CCNU nephrotoxicity following sustained remission in oat cell carcinoma.
    Silver HK; Morton DL
    Cancer Treat Rep; 1979 Feb; 63(2):226-7. PubMed ID: 221116
    [No Abstract]   [Full Text] [Related]  

  • 31. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
    Takita H; Marabella PC; Edgerton F; Rizzo D
    Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.
    Chiuten DF; Carr DT; Dhingra HM; Murphy WK; Spitzer G; Umsawasdi T; Bodey GP; Valdivieso M
    Cancer Treat Rep; 1986 Jun; 70(6):795-6. PubMed ID: 3015403
    [No Abstract]   [Full Text] [Related]  

  • 33. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
    Green MR
    J Clin Oncol; 2008 Jul; 26(19):3112-3. PubMed ID: 18591551
    [No Abstract]   [Full Text] [Related]  

  • 34. Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer.
    Richards F; Pajak TF; Cooper MR; Spurr CL
    Cancer Chemother Rep; 1973; 57(4):419-22. PubMed ID: 4357670
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 36. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
    Miller CF; Weltz MD; Heim WJ; Blom J
    Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
    [No Abstract]   [Full Text] [Related]  

  • 37. [Some aspects of advances in the chemotherapy of bronchogenic carcinoma].
    Skricková J; Pálková I; Spelda S; Babicková L; Kaplanová J; Kubová O
    Vnitr Lek; 2001 Aug; 47(8):561-7. PubMed ID: 15633398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth curve modification of measurable tumors by 75 mg/m2 of CCNU every 3 weeks.
    Israel L; Chahinian P; Accard JL; Choffel C; Combes PF; Danrigal A; Germouty J; Migueres J; Schaerer R; Sotto JJ
    Eur J Cancer (1965); 1973; 9(11-12):789-97. PubMed ID: 4804306
    [No Abstract]   [Full Text] [Related]  

  • 39. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
    Whitehead RP; Rosenbaum PR; Carbone PP
    Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
    Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.